You have no items in your shopping cart.
Human OTUB2 [orb2993593]Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 53.6 KDa. Observed: 52 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg- Human USP14 [orb2993616]
Unconjugated
SDS-PAGE: Greater than 85% as determined by reducing SDS-PAGE.
Predicted: 48.45 KDa. Observed: 52 KDa, reducing conditions
1 mg, 10 μg, 50 μg, 500 μg - Human UBE2T [orb2993619]
Unconjugated
Predicted: 24.7 KDa. Observed: 25-30 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human UBE2K [orb2993620]
Unconjugated
Predicted: 48.7 KDa. Observed: 45 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human UBE2H [orb2993621]
Unconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 47 KDa. Observed: 50 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human UBE2D4 [orb2993622]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 43.45 KDa. Observed: 40 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human UBE2A [orb2993623]
Unconjugated
SDS-PAGE: Greater than 80% as determined by reducing SDS-PAGE.
Predicted: 49 KDa. Observed: 45 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human SUMF1 [orb2993528]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 38.4 KDa. Observed: 38-48 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human ACE-2 [orb2993542]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 84.63 KDa. Observed: 103 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human KLK5 [orb2993543]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 95% as determined by SEC-HPLC. (QC verified)
Predicted: 30.65 KDa. Observed: 40 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg